Probiogen AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Probiogen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013197
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeutic proteins/antibodies, viral vaccines, biosimilar and biobetter development. It offers contract cell line development, contract process development, contract manufacturing of GMP and non-GMP, protein analytics, and cell-based assays. It develops various technologies for optimized biopharmaceutical manufacturing and analysis. The organization also develops virusproduction system, adcc enhancement, yield enhancement, innovative bioassays and other technologies. Probiogen is headquartered in Berlin, Germany.

Probiogen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Probiogen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Probiogen AG, Medical Devices Deals, 2011 to YTD 2017 9
Probiogen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Probiogen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ProBioGen Enters into Co-Development Agreement with PT Bio Farma 11
ProBioGen Enters into Agreement with Zymeworks 12
Licensing Agreements 13
Chiome Bioscience Enters into Licensing Agreement with ProBioGen 13
ProBioGen Enters into Licensing Agreement with Eucodis Bioscience 14
ProBioGen Enters into Licensing Agreement with Merus 15
ProBioGen Enters into Licensing Agreement with Tizona Therapeutics 16
ProBioGen Enters into Lincencing Agreement with Novartis for GlymaxX ADCC Technology 17
ProBioGen Enters Into Licensing Agreement With Merus For GlymaxX ADCC Technology 18
ProBioGen Expands Licensing Agreement With Emergent BioSolutions For AGE1.CR Cell Line 19
Ceva Sante Animale Enters Into Licensing Agreement With ProBioGen For AGE1.CR Avian Cell Line 20
ProBioGen Enters Into Licensing Agreement With INHIBRX For GlymaxX ADCC Technology 21
Boehringer Ingelheim Enters Into Licensing Agreement With ProBioGen 22
Probiogen AG – Key Competitors 23
Probiogen AG – Key Employees 24
Probiogen AG – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Probiogen AG, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Probiogen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Probiogen AG, Deals By Therapy Area, 2011 to YTD 2017 8
Probiogen AG, Medical Devices Deals, 2011 to YTD 2017 9
Probiogen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
ProBioGen Enters into Co-Development Agreement with PT Bio Farma 11
ProBioGen Enters into Agreement with Zymeworks 12
Chiome Bioscience Enters into Licensing Agreement with ProBioGen 13
ProBioGen Enters into Licensing Agreement with Eucodis Bioscience 14
ProBioGen Enters into Licensing Agreement with Merus 15
ProBioGen Enters into Licensing Agreement with Tizona Therapeutics 16
ProBioGen Enters into Lincencing Agreement with Novartis for GlymaxX ADCC Technology 17
ProBioGen Enters Into Licensing Agreement With Merus For GlymaxX ADCC Technology 18
ProBioGen Expands Licensing Agreement With Emergent BioSolutions For AGE1.CR Cell Line 19
Ceva Sante Animale Enters Into Licensing Agreement With ProBioGen For AGE1.CR Avian Cell Line 20
ProBioGen Enters Into Licensing Agreement With INHIBRX For GlymaxX ADCC Technology 21
Boehringer Ingelheim Enters Into Licensing Agreement With ProBioGen 22
Probiogen AG, Key Competitors 23
Probiogen AG, Key Employees 24

★海外企業調査レポート[Probiogen AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scania AB:企業の戦略・SWOT・財務情報
    Scania AB - Strategy, SWOT and Corporate Finance Report Summary Scania AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Par Pacific Holdings Inc (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings Inc (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AA PLC:企業の戦略・SWOT・財務情報
    AA PLC - Strategy, SWOT and Corporate Finance Report Summary AA PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Austevoll Seafood Asa
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • W. L. Gore & Associates Inc:医療機器:M&Aディール及び事業提携情報
    Summary W. L. Gore & Associates Inc (Gore) is a manufacturer and distributor of fluoropolymer products. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company has developed numerous products for medica …
  • First Pacific Co Ltd (142):企業の財務・戦略的SWOT分析
    First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Turkish Aerospace Industries Inc:企業の戦略・SWOT・財務分析
    Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Biomatrica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • PharmaCyte Biotech Inc (PMCB)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company’s technology is used for the treatment of advanced and inoperable pancreatic cancer, and diabetes. It develops …
  • Ascendance Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Martifer SGPS SA (MAR)-エネルギー分野:企業M&A・提携分析
    Summary Martifer SGPS S.A. (Martifer) is an industrial holding company. Through its subsidiaries, the company provides construction services to metal mechanical structures, aluminum and glass facades, and infrastructure facilities. It promotes and develops renewable energy projects in the wind secto …
  • Nippon Suisan Kaisha, Ltd.:企業の戦略・SWOT・財務情報
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Havells India Ltd (HAVELLS):電力:M&Aディール及び事業提携情報
    Summary Havells India Limited (Havells) is a fast moving electrical goods (FMEG) company that primarily designs, produces, distributes and sells a range of industrial and consumer electrical products. Its offers various consumer support and industrial electrical solutions support related products. T …
  • Ocwen Financial Corporation:企業のM&A・事業提携・投資動向
    Ocwen Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ocwen Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Pakistan Water and Power Development Authority:発電所・企業SWOT分析
    Pakistan Water and Power Development Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務分析
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Zelan Bhd:企業の戦略・SWOT・財務情報
    Zelan Bhd - Strategy, SWOT and Corporate Finance Report Summary Zelan Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆